Ranolazine Tablet, Film Coated, Extended Release
Product Images NDC 72319-021

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 72319-021). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by I3 Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemicalstructure (Chemicalstructure)

FDA Label Image

Container-1000mg-60tablets (Container 1000mg 60tablets)

Manufacturer: i3 Pharmaceuticals. Product name: Ranolazine ERSET Extended-Release Tablets, strength: 193 mg. Packaging: 60 Tablets. This description provides basic information about the medication and its manufacturer, as well as dosage strength and packaging.*

FDA Label Image

Container-500mg-60tablets (Container 500mg 60tablets)

This appears to be a pharmaceutical drug information sheet. The name of the drug is Ranolazine, which is in the form of extended-release tablets. The sheet also includes the manufacturer's name, Ecnmmoons aorke and the Rk NoC 7231902102. There is information about the standard dosage and package size. Additionally, there is a reference code at the end of the text.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.